Artivion | CRY - Current Assets


Artivion reported $371.38M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 345.53M 31.84M Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 7.97B 712M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Inogen USD 203.72M 594K Sep/2025
Integra LifeSciences USD 1.19B 19.46M Jun/2026
J&J USD 59.77B 601M Jun/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 446.13M 15.39M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
ResMed USD 4.32B 260.68M Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.88B 16.21M Jun/2026
Terumo JPY 906.6B 45.57B Jun/2026
Trinity Biotech USD 35.9M 382K Dec/2025